The term Inactive DUSP27 Activators suggests a class of compounds that interact with a protein referred to as DUSP27 that is, by default, in an inactive state. If we extrapolate based on the known dual-specificity phosphatases (DUSPs) family, DUSP27 would likely be an enzyme that has the ability to dephosphorylate both tyrosine and serine/threonine residues on its substrate proteins. In this speculative class, Inactive DUSP27 Activators would be designed to bind to this inactive phosphatase, catalyzing a change in its conformation or dynamics that results in an active enzyme. The chemical structures of these activators might be diverse, potentially including small molecules, peptides, or other biologically active substances that have been crafted to interact with specific domains of DUSP27, such as the phosphatase domain, without inducing enzymatic activity.
The discovery and development of these Inactive DUSP27 Activators would require an initial understanding of the DUSP27 protein's structure and mechanism of inactivation. Should the protein exist, researchers would need to delineate the inactive conformation of DUSP27 and identify any regulatory regions or interacting partners that maintain its inactivity. Potential activators might be identified through high-throughput screening of chemical libraries to find molecules that bind to and affect the conformation of DUSP27. Such molecules might act by disrupting interactions that stabilize the inactive state or by inducing a conformational shift that predisposes the enzyme toward an active state. Once candidate molecules are identified, their efficacy and specificity would need to be confirmed through a series of biochemical assays, which might include measuring binding affinity, analyzing the kinetics of conformational changes, and evaluating the impact on the phosphatase activity of DUSP27 in vitro.
Artikel 1 von 10 von insgesamt 11
Anzeigen:
Produkt | CAS # | Katalog # | Menge | Preis | Referenzen | Bewertung |
---|---|---|---|---|---|---|
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Reaktive Sauerstoffspezies wie Wasserstoffperoxid können Stressreaktionswege aktivieren, die möglicherweise DUSP27 als Rückkopplungsregulator hochregulieren. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $106.00 $765.00 | 3 | |
Induziert zellulären Stress und aktiviert die MAPK-Signalwege, was zur Induktion der DUSP27-Expression als Teil der Reaktion führen könnte. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Als PKC-Aktivator kann PMA die MAPK-Signalwege modulieren und die DUSP27-Expression beeinflussen. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Als MEK-Inhibitor, der der MAPK vorgelagert ist, könnte U0126 die Rückkopplungsregulierung der MAPKs beeinträchtigen und möglicherweise die DUSP27-Expression beeinflussen. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Es hemmt die Proteinsynthese und kann zelluläre Stressreaktionen auslösen, die stressreagierende Gene wie DUSP27 hochregulieren können. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Ein synthetisches Glukokortikoid, das die Genexpression beeinflussen kann und die Expression von MAPK-regulierenden Genen wie DUSP27 beeinflussen könnte. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Weist entzündungshemmende Eigenschaften auf und kann Signalwege modulieren, die die Expression von Genen wie DUSP27 beeinflussen. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Ein Proteinsyntheseinhibitor, der stressaktivierte Proteinkinasen aktivieren kann und möglicherweise die Expression von DUSP27 beeinflusst. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Ein p38-MAPK-Inhibitor, der die Expression von nachgeschalteten regulatorischen Genen wie DUSP27 innerhalb des MAPK-Signalwegs beeinflussen könnte. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Ein Inhibitor der c-Jun N-terminalen Kinase (JNK), der die MAPK-Signalkaskade modulieren und die DUSP27-Expression beeinflussen könnte. |